MUDr. Eliška Bartečková, Ph.D.

Curriculum vitae

Person-related identification information

• Name, surname, titles: Eliška Bartečková, MUDr., Ph.D.
• Date of birth: 28/01/1982
• Place of birth: Havířov, Czech Republic

Department/Faculty/University

• Department of Psychiatry, University Hospital Brno and Masaryk University

Function, current position

• Deputy for education
• Supervisor of Ph.D. students
• Tutor for pre-gradual students

Education and academic qualifications

• 2001 – 2013: FACULTY OF MEDICINE, MASARYK UNIVERSITY, BRNO, CZECH REPUBLIC:
• 2013: Ph.D. in psychiatry (Dissertation title: Effect of pharmacogenetic and pharmacokinetic factors on the course and treatment of first episode schizophrenia)
• 2012: Specialty board examination in psychiatry
• 2001 – 2007: General medicine – MD title

Professional experience

• 2007 - present: DEPARTMENT OF PSYCHIATRY, UNIVERSITY HOSPITAL BRNO AND MASARYK UNIVERSITY, BRNO, CZECH REPUBLIC:
• 2015 - present: Deputy for education
• 2013 - present: Chief doctor of the mood disorder ward
• 2013 - present: College tutor
• 2007 - 2013: Psychiatrist
• 2007 - 2013: Postgraduate student
• 2012 - 2014: CEITEC - CENTRAL EUROPEAN INSTITUTE OF TECHNOLOGY, MASARYK UNIVERSITY, BRNO, CZECH REPUBLIC
• Researcher
• 2010: UNIVERSITY MEDICAL CENTRE UTRECHT, NETHERLANDS: Researcher, 6-month academic stay sponsored by Marie Curie Research Training Network

Teaching activities

• 2007 – present: DEPARTMENT OF PSYCHIATRY, UNIVERSITY HOSPITAL BRNO AND MASARYK UNIVERSITY:
• 2015 – present: Supervisor of Ph.D. students
• 2015 – present: Deputy for education
• 2007 – present: College tutor for pre-gradual students

Research activities

• 2008 – present: Phase III clinical trials in patients with schizophrenia and affective disorders
• 2016 – present: Research grant Ministry of Health of the Czech Republic No 16-31457A: Neurobiological mechanisms of functional neurological disorders
• 2015 – present: Research grant of Ministry of Health of the Czech Republic No 15-31063A: Cellular-signature profiling: leading to tailored treatment for Schizophrenic patients
• 2015 – present: Research grant of Ministry of Health of the Czech Republic No 15-30062A: Impulsivity phenotypes and their clinical impact in neuropsychiatric disorders
• 2008 – 2011: Research grant IGA MZ ČR č. NS9676-4: The influence of pharmacogenetic and pharmacokinetic factors on the efficacy and safety of the first schizophrenia episodes therapy

Professional stays abroad

• 2010: University Medical Centre Utrecht, Netherlands
• Researcher, 6-month academic stay sponsored by Marie Curie Research Training Network

Other academic activities

• 2016 - present: member of Ethics committee of Faculty of medicine, Masaryk University, Brno, Czech republic

Non-university activities

• Member of the Czech Neuropsychopharmacological Society
• Member of the Czech Psychiatric Society

Most significant professional accomplishments

• 2011 - Award of the Committee of Czech Psychiatric Society for young researcher

Major publications

• HOŘÍNKOVÁ, Jana a Richard BARTEČEK. Knowledge and attitudes of Masaryk University medical students towards electroconvulsive therapy (ECT). MEFANET journal. Brno: Facta Medica, 2016, roč. 4, č. 1, s. 33-43. ISSN 1805-9163. info
• KAŠPÁREK, Tomáš; Michal DREISIG a Richard BARTEČEK. Alkoholový odvykací stav a delirium - od patofyziologie k léčbě. Česká a slovenská neurologie a neurochirurgie. Praha: Nakladatelské a tiskové středisko ČLS JEP, 2014, roč. 77, č. 2, s. 153-157. ISSN 1210-7859. info
• DREISIG, Michal; Richard BARTEČEK a Tomáš KAŠPÁREK. CÍLE MOLEKULÁRNĚGENETICKÉ ANALÝZY ZÁVISLOSTI NA ALKOHOLU. Česká a slovenská psychiatrie. Praha: Česká lékařská společnost J.E.Purkyně, 2013, roč. 109, č. 6, s. 289-297. ISSN 1212-0383. info
• JUŘICA, Jan; Richard BARTEČEK; Alexandra ŽOURKOVÁ; Eva PINDUROVÁ; Alexandra ŠULCOVÁ; Tomáš KAŠPÁREK a Ondřej ZENDULKA. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. HOBOKEN: WILEY-BLACKWELL, 2012, roč. 37, č. 4, s. 486-490. ISSN 0269-4727. Dostupné z: https://doi.org/10.1111/j.1365-2710.2012.01333.x. URL info
• BARTEČEK, Richard; Jan JUŘICA; Jana ZRUSTOVA; Tomáš KAŠPÁREK; Eva PINDUROVÁ a Alexandra ŽOURKOVÁ. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone. Neuroendocrinology Letters. Stockholm: Maghira and Maas Publications, 2012, roč. 33, č. 2, s. 236-244. ISSN 0172-780X. URL info
• STEIN, Jason a Richard BARTEČEK. Identification of common varants associated with human hippocampal and intracranial volumes. Nature genetics. United States: Nature Publishing Group, 2012, roč. 44, č. 5, s. 552-561. ISSN 1061-4036. Dostupné z: https://doi.org/10.1038/ng.2250. info
• BARTEČEK, Richard; Tomáš KAŠPÁREK a Eva ČEŠKOVÁ. Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia. Central European Journal of Medicine. Warsaw (Poland): Versita, 2011, roč. 6, č. 5, s. 662-664. ISSN 1895-1058. Dostupné z: https://doi.org/10.2478/s11536-011-0055-8. info
• JUŘICA, Jan; Richard BARTEČEK; Ondřej ZENDULKA; Tomáš KAŠPÁREK; Eva PINDUROVÁ a Alexandra ŠULCOVÁ. CYP2D6 phenotype and genotype determination with respect to prediction of therapeutic response in first episode schizophrenia treatment. In The 61th Czech-Slovak Pharmacological days and EPHAR symposium. 2011. ISBN 978-80-7399-770-0. info
• BARTEČEK, Richard; Jan JUŘICA; Jana ZRŮSTOVÁ; Eva PINDUROVÁ; Tomáš KAŠPÁREK a Alexandra ŽOURKOVÁ. Aktivita CYP2D6 u pacientů léčených risperidonem. Česká a slovenská psychiatrie. 2011, roč. 107, č. 6, s. 327–334. ISSN 1212-0383. info
• FLODROVÁ, Eva; Jan JUŘICA; Richard BARTEČEK; Renata GAILLYOVÁ a Alexandra ŽOURKOVÁ. Molecular genetic identification of the major CYP2D6 alleles and utilization in psychiatric treatment of depression. European Journal of Human Genetics. London: NATURE PUBLISHING GROUP, 2009, roč. 2009, 17 Supp2, s. 221. ISSN 1018-4813. info

2024/04/02